from Yahoo Finance https://ift.tt/2YzHbIo
-
Michael Cola Is The CEO, President & Director of Cerecor Inc. (NASDAQ:CERC) And They Just Picked Up 132% More Shares
-
AstraZeneca Inks Europe Deal For 400M Covid-19 Vaccine Doses
AstraZeneca (AZN) has agreed to supply up to 400 million doses of the University of Oxford’s COVID-19 vaccine, AZD1222, to Europe’s Inclusive Vaccines Alliance (IVA), with deliveries starting by the end of 2020.Total manufacturing capacity for AZD1222 now stands at two billion doses, says AZN.Spearheaded by Germany, France, Italy and the Netherlands, the IVA says it aims to accelerate the supply of the vaccine and to make it available to other European countries that wish to participate in the initiative.At the same time, UK-based AstraZeneca continues to build several global supply chains, including for Europe. “The company is seeking to expand manufacturing capacity further and is open to collaborating with other companies in order to meet its commitment to support access to the vaccine at no profit during the pandemic” AZN states.Pascal Soriot, CEO of AstraZeneca, commented: “With our European supply chain due to begin production soon, we hope to make the vaccine available widely and rapidly.”Indeed, the company recently entered similar agreements with the UK, US, the Coalition for Epidemic Preparedness Innovations and Gavi the Vaccine Alliance for 700 million doses. It has also agreed a license with the Serum Institute of India for the supply of an additional one billion doses for low and middle-income countries.Oxford University last month announced the start of a Phase II/III UK trial of AZD1222 in about 10,000 adult volunteers. Other late-stage trials are due to begin in a number of countries. AstraZeneca recognizes that the vaccine may not work but is nonetheless progressing the clinical program with speed and scaling up manufacturing at risk.AZD1222 uses a replication-deficient chimpanzee viral vector based on a weakened version of a common cold virus that causes infections in chimpanzees and contains the genetic material of SARS-CoV-2 spike protein. After vaccination, the surface spike protein is produced, priming the immune system to attack COVID-19 if it later infects the body.Shares in AstraZeneca are up 3% year-to-date, and analysts are, on average, predicting that 20% further upside potential lies ahead. This comes with a Strong Buy consensus based on 4 recent buy ratings. (See AstraZeneca stock analysis on TipRanks).Related News: Oxford Biomedica Clinches Manufacturing Deal For AstraZeneca’s Covid-19 Vaccine 5 Promising Covid-19 Vaccines Picked For Trump’s Operation Warp Speed What Would a Merger Mean for Gilead? Top Analyst Weighs In More recent articles from Smarter Analyst: * Medtronic Succeeds In Critical US Trial For New Insulin Pump * American Express Scores China Go-Ahead In Milestone Moment * Sorrento Edges Higher On Debt Repayment As Top Analyst Says Buy * Activist Investor Jana Partners Builds 5.9% Stake in Perspecta; Stock Jumps 9% In Pre-Market
from Yahoo Finance https://ift.tt/2B7ZHiK
-
The most explosive ASX tech shares you can buy today
On Saturday I looked at the healthcare sector and revealed how it has vastly outperformed the S&P/ASX 200 Index (ASX: XJO) over the last five years.
It isn’t the only side of the market to have outperformed the index over the period. Another area which has been on fire has been the tech sector.
During this time the S&P/ASX 200 Information Technology index has gained a sizeable 84.6%.
But don’t worry if you missed these gains, because I believe the sector can continue to outperform over the next five years.
But which shares should you buy? I believe the three ASX tech shares listed below have the potential to generate market beating returns for investors. Here’s why:
Afterpay Ltd (ASX: APT)
I think this payments company is an ASX tech share to buy with a long term view. Although its shares have been on fire this year, I still believe they can go materially higher in the future. This is due to the growing popularity of buy now pay later with consumers and retailers, its US$5 trillion opportunity in the United States, and expansion opportunities in mainland Europe and Asia. The latter could be supported by US$500 billion WeChat owner, Tencent Holdings. It recently became a substantial shareholder of Afterpay.
Altium Limited (ASX: ALU)
Another ASX tech share to consider buying is Altium. It is a printed circuit board design software company which is benefiting greatly from the rapidly growing Internet of Things (IoT) market. The explosion of connected devices globally has been driving increasing demand for its Altium Designer software. So much so, this year Altium expects to achieve 50,000 subscribers. After which, it is aiming for 100,000 subscribers by FY 2025. Together with its other promising businesses such as NEXUS and Octopart, I feel Altium is well-placed to deliver strong long term earnings growth.
Appen Ltd (ASX: APX)
I final ASX tech share to look at is Appen. The artificial intelligence (AI) company has a million-plus team of crowd-sourced experts which prepare the data to go into the AI and machine learning models of some of the world’s largest tech companies. This includes the likes of Facebook, Microsoft, and Apple. In respect to Apple, Appen helped the tech behemoth develop its intelligent assistant, Siri. The good news is that AI is growing in importance for businesses. I believe this means demand for its services will continue to grow over the next decade and underpin strong earnings growth.
And here are more exciting shares which could be destined for big things…
We hear it over and over from investors, “I wish I had bought Altium or Afterpay when they were first recommended by The Motley Fool. I’d be sitting on a gold mine!” And it’s true.
And while Altium and Afterpay have had a good run, we think these 5 other stocks are screaming buys. And you can buy them now for less than $5 a share!
*Extreme Opportunities returns as of June 5th 2020
More reading
- How to earn $50,000 in dividends each year with ASX shares
- How I would build a balanced portfolio worth $100,000 with 10 ASX shares
- Here’s how you invest in super to get a free $500
- 3 ASX shares I’d buy if the market hits 23 March levels again
- ASX 200 falls 1.9%, big 4 ASX banks retreat
James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. owns shares of AFTERPAY T FPO and Altium. The Motley Fool Australia owns shares of Appen Ltd. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.
The post The most explosive ASX tech shares you can buy today appeared first on Motley Fool Australia.
from Motley Fool Australia https://ift.tt/3cZaNEd
The Latest
-
NVDA | Will NVIDIA Get a Boost From New Gaming Laptops? March was a record quarter for digital spending on games.
-
Most Anticipated Earnings Releases for the trading week beginning May 11th, 2020
-
Mark Cuban’s Secret Shopper Study Finds That 96% of Dallas Businesses Don’t Comply With Reopening Guidelines. This is going to get bad.
-
Strategy Analysis